Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Education
  • General

This Energy Company Is Up More Nearly 500% In The Last Year, Destroying Tesla, Apple, And More

By Aaron Bry
July 25, 12:02 PM
This past year has been tough for stocks: the S&P 500 is down more than 10%, the Nasdaq 100 down more than 18%. But, not every stock is down. A lot of energy stocks have been performing well, especially with the Russian invasion of Ukraine tightening supply throughout the world.

AAPL

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • News
  • Penny Stocks

HOOKIPA Gets FDA Nod For Initial-Stage Prostate Cancer Study

By Ragothaman Srinivasan
July 25, 11:49 AM
The U.S. Food and Drug Administration (FDA) has accepted HOOKIPA Pharma’s (NASDAQ: HOOK) Investigational New Drug (IND) application for HB-300, a novel arenaviral immunotherapy for the treatment of metastatic castration-resistant prostate cancer.

HOOK

Read More
1 minute read
  • General
  • News
  • Politics

President Biden To Virtually Meet With CEOs Of Medtronic, Lockheed Martin And Cummins On Semiconductor Chips Legislation

By Benzinga Newsdesk
July 25, 11:32 AM
-Reuters

CMI

Read More
1 minute read
  • Entertainment
  • Gaming
  • General
  • News
  • Small Cap

Funko Plans To Develop Video Games In Partnership With 10:10 Games

By Shivani Kumaresan
July 25, 11:14 AM
Pop culture and lifestyle brand Funko Inc (NASDAQ:FNKO) is planning to enter the video game market through a partnership with game developer 10:10…

FNKO

Read More
2 minute read
  • Entertainment
  • General
  • News
  • Sports

National Football League Announces New Streaming Launch: Here’s What Fans Will Get To See

By Chris Katje
July 25, 11:11 AM
The National Football League is launching its own streaming service for the first time. Here’s a look at what’s included and what is missing from the new product.

AAPL

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • News

FDA Accepts AstraZeneca’s Submission For Low Breast Cancer Candidate Under Priority Review

By Ragothaman Srinivasan
July 25, 10:21 AM
The United States Food and Drug Administration (FDA) has accepted to review the supplemental Biologics License Application (sBLA) of AstraZeneca (NASDAQ: AZN) and Daiichi Sankyo’s lead asset ENHERTU (fam-trastuzumab deruxtecan-nxki) for the treatment of adult patients with unresectable

AZN

Read More
1 minute read
  • General
  • Politics

Senator Manchin Says Tested Positive For COVID-19

By Benzinga Newsdesk
July 25, 9:45 AM
-Bloomberg

SPY

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News
  • Penny Stocks

Soligenix Partners With SERB Pharmaceuticals To Supply Ricin Antigen For Ricin Toxin Poisoning Treatment

By Vandana Singh
July 25, 9:16 AM
Soligenix Inc (NASDAQ:SNGX) has signed a worldwide license to supply its ricin antigen to SERB Pharmaceuticals for novel therapeutic treatment against…

SNGX

Read More
2 minute read
  • Biotech
  • General

IceCure Announces Regulatory Filing Submission For Approval Of ProSense In Canada For Indications Including Ablation Of Benign And Malignant Breast Tumors

By Bill Haddad
July 25, 8:05 AM
Canadian hospitals and health care providers have expressed strong interest in ProSense® as they seek minimally invasive treatments for breast and other tumors CAESAREA, Israel, July 25, 2022 /PRNewswire/

ICCM

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • News

HOOKIPA Pharma Announces FDA Accepts Co.’s Investigational New Drug Application For HB-300 For The Treatment Of Metastatic Castration-resistant Prostate Cancer

By Benzinga Newsdesk
July 25, 8:03 AM
Novel arenaviral immunotherapy is directed against the prostate cancer targets PAP and PSA; Phase 1/2 trial to commence by early 2023 Drug Master File (DMF) accepted to support future FDA submissions

HOOK

Posts pagination

Previous 1 … 2,295 2,296 2,297 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service